GlassScriptPhysician profile
Susan P King
NPI 1467665109
$1,316.57
in general payments reported to CMS, 2019-2025
14 companies · $35.32 in 2025
The $35.32 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $584 · 2020: $218 · 2021: $324 · 2023: $24.73 · 2024: $130 · 2025: $35.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $189.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $263.33 | 2019-2021 | |
| Organogenesis INC. | $160.32 | 2021-2025 | Apligraf |
| Boston Scientific Corporation | $129.83 | 2024 | |
| Horizon Therapeutics Plc | $123.48 | 2019 | |
| Bioventus LLC | $118.44 | 2021 | |
| Stryker Corporation | $110.42 | 2019 | |
| Acell, INC. | $101.43 | 2019 | |
| Osteomed LLC | $98.71 | 2019 | |
| Paragon 28, INC. | $69.10 | 2019-2020 | |
| Depuy Synthes Sales INC. | $51.12 | 2020 | |
| Integra Lifesciences Corporation | $28.25 | 2019-2020 | |
| Wright Medical Technology, INC. | $24.88 | 2019 | |
| Progenacare Global, LLC | $24.73 | 2023 | |
| Biocomposites INC | $12.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.